Rahsaan Thompson

Chief Legal & Compliance, Zevra Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.0M

Companies

Latest trade

Aug 14, 2026

Companies

Zevra Therapeutics, Inc.Chief Legal & Compliance −$1.0M

Trades

ZVRA Sold 42,666 shares at $11.13 · planned $0.5M Aug 14

ZVRA Sold 34,557 shares at $12.68 · planned $0.4M Jun 22

ZVRA Sold 1,794 shares at $11.30 · planned $0.0M May 11

ZVRA Sold 4,080 shares at $8.83 · planned $0.0M Jan 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.